| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.26 | 6e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.25 | 3e-06 |